.
Investigation of possibility to use fullerene nanoparticles in development of novel therapeutic agents against autoimmune thyroiditis
Project/agreement No.
132305
Project funding
20 000.00 EUR
Project manager
Project realization
01.04.2019. - 31.03.2020.
Aim
The aim of this study is to investigate the use of fullerene nanoparticles as an opportunistic adjuvant/delivery agent for synthetic peptide vaccine development and to test fullerene antioxidant activity in thyrocytes’ acquired from patients with autoimmune thyroiditis.